Long‐term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals
Open Access
- 18 April 2023
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 43 (8) , 1699-1713
Abstract
Background & AimsNonalcoholic fatty liver disease (NAFLD) is a major health burden associated with the metabolic syndrome leading to liver fibrosis, cirrhosis and ultimately liver cancer. In humans, the PNPLA3 I148M polymorphism of the phospholipase patatin-like phospholipid domain containing protein 3 (PNPLA3) has a well-documented impact on metabolic liver disease. In this study, we used a mouse model mimicking the human PNPLA3 I148M polymorphism in a long-term high fat diet (HFD) experiment to better define its role for NAFLD progression. MethodsMale mice bearing wild-type Pnpla3 (Pnpla3(WT)), or the human polymorphism PNPLA3 I148M (Pnpla3(148M/M)) were subjected to HFD feeding for 24 and 52 weeks. Further analysis concerning basic phenotype, inflammation, proliferation and cell death, fibrosis and microbiota were performed in each time point. ResultsAfter 52 weeks HFD Pnpla3(148M/M) animals had more liver fibrosis, enhanced numbers of inflammatory cells as well as increased Kupffer cell activity. Increased hepatocyte cell turnover and ductular proliferation were evident in HFD Pnpla3(148M/M) livers. Microbiome diversity was decreased after HFD feeding, changes were influenced by HFD feeding (36%) and the PNPLA3 I148M genotype (12%). Pnpla3(148M/M) mice had more faecal bile acids. RNA-sequencing of liver tissue defined an HFD-associated signature, and a Pnpla3(148M/M) specific pattern, which suggests Kupffer cell and monocytes-derived macrophages as significant drivers of liver disease progression in Pnpla3(148M/M) animals. ConclusionWith long-term HFD feeding, mice with the PNPLA3 I148M genotype show exacerbated NAFLD. This finding is linked to PNPLA3 I148M-specific changes in microbiota composition and liver gene expression showing a stronger inflammatory response leading to enhanced liver fibrosis progression.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (HA 7246/2–1, Tr 285/10–2)
This publication has 40 references indexed in Scilit:
- Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver DiseasePLOS ONE, 2013
- High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling PathwayPLOS ONE, 2012
- Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosisJournal of Clinical Investigation, 2012
- Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver DiseaseJournal of Biological Chemistry, 2011
- Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†Hepatology, 2010
- Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cellsCell Research, 2009
- Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell functionNature Immunology, 2009
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Is visceral obesity the cause of the metabolic syndrome?Annals of Medicine, 2006
- High-throughput engineering of the mouse genome coupled with high-resolution expression analysisNature Biotechnology, 2003